Evidence map›Paper›PMID 23437132›Full record

ArticlePloS one2013

TSLP promotes induction of Th2 differentiation but is not necessary during established allergen-induced pulmonary disease.

Sihyug Jang, Susan Morris, Nicholas W Lukacs

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Advanced In Vitro Three-Dimensional Skin Models of Atopic Dermatitis.Tissue engineering and regenerative medicine · 2023
    Review
  4. Review
  5. TSLP, IL-33, and IL-25: Not just for allergy and helminth infection.The Journal of allergy and clinical immunology · 2022
    Review
  6. T-cell responses in asthma exacerbations.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2022
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. TSLP signaling in CD4Science signaling · 2018
    Article
  15. Journal of immunology (Baltimore, Md. : 1950) · 2017
    Article
  16. Article
  17. Article
  18. Thymic Stromal Lymphopoietin Improves Survival and Reduces Inflammation in Sepsis.American journal of respiratory cell and molecular biology · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Sihyug JangDepartment of Pathology, The University of Michigan, Ann Arbor, Michigan, USA.
Susan Morris
Nicholas W Lukacs
University of Michigan–Ann Arbor · USMichigan United · US

Funding

THE ROLE OF SCF IN EOSINOPHIL LUNG INFLAMATIONR01HL059178 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUKACS, NICHOLAS W · 1999 to 2013
$3.3M
SIV--MACAQUE MODEL FOR FETAL INFECTION AND DISEASER01AI032302 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI MURPHEY-CORB, MICHAEL A · 1991 to 1994
–
NHLBI NIH HHS R01 HL059178NIAID NIH HHS AI032302
6 · The paper itself

Abstract

Thymic stromal lymphopoietin (TSLP) has been implicated in the development of allergic inflammation by promoting Th2-type responses and has become a potential therapeutic target. Using in vitro T cell differentiation cultures we were able to validate that TSLP played a more critical role in the early development of Th2 immune responses with less significant enhancement of already developed Th2 responses. Adoptive transfer of naive DO11.10 ovalbumin-specific T cells followed by airway exposure to ovalbumin showed an early impairment of Th2 immune response in TSLP-/- mice compared to wild type mice during the development of a Th2 response. In contrast, transfer of already differentiated Th2 cells into TSLP-/- mice did not change lung pathology or Th2 cytokine production upon ovalbumin challenge compared to transfer into wild type mice. An allergen-induced Th2 airway model demonstrated that there was only a difference in gob5 expression (a mucus-associated gene) between wild type and TSLP-/- mice. Furthermore, when allergic animals with established disease were treated with a neutralizing anti-TSLP antibody there was no change in airway hyperreponsiveness (AHR) or Th2 cytokine production compared to the control antibody treated animals, whereas a change in gob5 gene expression was also observed similar to the TSLP-/- mouse studies. In contrast, when animals were treated with anti-TSLP during the initial stages of allergen sensitization there was a significant change in Th2 cytokines during the final allergen challenge. Collectively, these studies suggest that in mice TSLP has an important role during the early development of Th2 immune responses, whereas its role at later stages of allergic disease may not be as critical for maintaining the Th2-driven allergic disease.

Indexed as

AllergensAnimalsAntigensCell DifferentiationCockroachesCytokinesDendritic CellsHypersensitivityImmunityLung DiseasesLymph NodesMiceMice, Inbred BALB CSignal TransductionTh2 CellsThymic Stromal LymphopoietinAllergensAntigensCytokinesThymic Stromal Lymphopoietin

Identifiers

PMID23437132
PMCPMC3577905
OpenAlexW2029600246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.